booster; booster- sore arm; booster- did have muscle aches and 2 days afterwards it was gone; booster- red dots, like a rash or pimples, on his right arm on the triceps area and on the bicep area a little bit; the bumps on his right arm and on his left arm as well on the bicep triceps area on his upper arm. It was the same red, little bumps/he noticed was kind of the same sort of rashes or small bumps; after the booster dose, that he had kind of like red dots; all three of those sets of bumps they were all itchy; When he moved his arm up and down in a motion he could feel pain with that on the bump; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Nov2021 (Lot number: FG3522) at the age of 26 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Lactose intolerance" (ongoing), notes: Verbatim: Lactose intolerance; "seasonal allergies" (unspecified if ongoing); "Dry eyes" (unspecified if ongoing). Concomitant medication(s) included: FLONASE taken for seasonal allergy (ongoing); VITAMIN D (ongoing); PROBIOTIC (ongoing); HYDROEYE taken for dry eye, start date: 2021 (ongoing). Vaccination history included: Bnt162b2 (Dose: 01, Anatomical Location: left arm, Outcome of reaction/event: Recovered/Resolved), administration date: 06Mar2021, when the patient was 25 years old, for COVID-19 Immunization, reaction(s): "sore arm"; Bnt162b2 (Dose: 02, Lot Number: EK8730, Anatomical Location: left arm, Outcome of reaction/event: Recovered/Resolved), administration date: 27Mar2021, when the patient was 25 years old, for COVID-19 Immunization, reaction(s): "Sore arm". The following information was reported: IMMUNISATION (non-serious) with onset 09Nov2021, outcome "unknown", described as "booster"; PAIN IN EXTREMITY (non-serious) with onset Nov2021, outcome "recovered" (Nov2021), described as "booster- sore arm"; MYALGIA (non-serious) with onset Nov2021, outcome "recovered" (Nov2021), described as "booster- did have muscle aches and 2 days afterwards it was gone"; RASH (non-serious) with onset Nov2021, outcome "recovered" (Nov2021), described as "booster- red dots, like a rash or pimples, on his right arm on the triceps area and on the bicep area a little bit"; RASH (non-serious) with onset Nov2021, outcome "not recovered", described as "few days after he had discovered the bumps on his right arm and on his left arm as well on the bicep triceps area on his upper arm.It was the same red,little bumps/he noticed was kind of the same sort of rashes or small bumps were on back of his neck"; ERYTHEMA (non-serious) with onset Nov2021, outcome "recovered" (Nov2021), described as "after the booster dose, that he had kind of like red dots"; PRURITUS (non-serious) with onset Nov2021, outcome "unknown", described as "all three of those sets of bumps they were all itchy"; PAIN (non-serious) with onset Nov2021, outcome "not recovered", described as "When he moved his arm up and down in a motion he could feel pain with that on the bump". Therapeutic measures were taken as a result of pain in extremity, myalgia, rash, rash, erythema, pruritus, pain.  Additional information: No other vaccinations was received within four weeks prior to the first administration date of the suspect vaccine.No emergency room visit.  No follow-up attempts are possible. No further information is expected.